Diabetes drug may reduce cardiovascular risks
13th Nov 2006, 18:39 GMT
A drug commonly used to increase the body's sensitivity to insulin may slow the progression of cardiovascular disease in patients with type 2 diabetes, according to a study at the University of Illinois at Chicago.
Diabetes drug may reduce cardiovascular risks related news:
- Dairy Council of California Helps Hispanic Families Achieve Healthier Lifestyles — Hispanic Business Magazine
- Diabetes drug may cut heart risks — MSNBC.com: Health
- Diabetes drug may cut heart risks: study (Reuters) — Yahoo! Health: Health News
- Diabetes drug may cut heart risks: study — Reuters: Health
- First Metformin Gum Patent — The Diabetes Blog
- Increases in overweight and obesity jeopardize children's long-term health — OnMedica Latest News
- Delay for FDA approval of diabetes drug — WISTV - Health
- Novartis diabetes drug delayed — FT.com - Companies
- Diabetes drug stalls heart disease — United Press International - Health Business
- U.S. delays Novartis diabetes drug — Marketplace by Bloomberg - International Herald Tribune
Latest news from EurekAlert! - Medicine and Health:
- Enbrel provides sustained clinical improvements for ankylosing spondylitis for up to 3 years
- Enbrel first biologic with up to 9 years rheumatoid arthritis safety, sustained efficacy data
- UCSD computer scientist wins Young Investigator Award, research on snake venom proteins highlighted
- Why do insects like to eat some plants more than others?
- Opposites do not attract
- Wild gorillas carriers of an SIV virus close to the AIDS virus
- New data show ACTOS (pioglitazone HCl) halted progression of atherosclerosis as indicated by CIMT
- Pourquié lab identifies genes involved in formation of vertebral precursors
- Artificial cornea offers better results for infants, some blind patients
- Healthier kids just the click of a remote away